Imagenetix Announces 1-Tetradecanol Complex Acts to Inhibit Bacteria and Enzymes Associated with Oral Disease, Sepsis and Inflammation

by Imagenetix on May 8, 2006

SAN DIEGO–(BUSINESS WIRE)–May 8, 2006–Imagenetix (OTCBB:IAGX – News) today announced the successful completion of in vitro studies demonstrating the significant inhibitory function of its novel pharma compound, 1-tetradecanol complex (1-TDC). The main findings include: 1-TDC significantly inhibited the growth of Actinomyces viscosus, a microbe that has been shown to play a major role in oral [...]

{ Comments on this entry are closed }

Imagenetix Commissions New Study to Evaluate Celadrin® Capsules for Patients with Knee Osteoarthritis

by Imagenetix on March 20, 2006

SAN DIEGO–(BUSINESS WIRE)–March 20, 2006–Imagenetix Inc. (OTCBB: IAGX – News), a company focused on joint health and joint health-related markets, today announced it has commissioned a new multi-site study to measure the effectiveness of its Celadrin® oral capsules for improving overall joint health in patients with osteoarthritis of the knee. The primary purpose of this [...]

{ Comments on this entry are closed }

Imagenetix Second Quarter Revenue up 95 Percent

by Imagenetix on November 22, 2005

SAN DIEGO–(BUSINESS WIRE)–Nov. 22, 2005–Imagenetix, Inc. (OTCBB:IAGX – News), an innovator of scientifically tested, natural-based, proprietary bioceutical products that enhance human health, today announced that, for the second fiscal quarter ended September 30, 2005, it reported revenue of $2,016,295, a 95 percent increase on revenues of $1,034,146 reported in the same quarter of the prior [...]

{ Comments on this entry are closed }

Imagenetix Licenses Patent Related to Body Fat Control

by Imagenetix on November 16, 2005

SAN DIEGO–(BUSINESS WIRE)–Nov. 16, 2005–Imagenetix, Inc. (OTCBB:IAGX – News), an innovator of scientifically tested, natural-based, proprietary bioceutical products that enhance human health, today announced it has signed a license agreement with the University of Minnesota for the exclusive rights to the University’s recently awarded patent covering a natural compound for lowering the body’s levels of [...]

{ Comments on this entry are closed }

Jeffrey McGonegal Appointed to Imagenetix Board of Directors and Appointed Chairman of the Audit Committee and Its Financial Expert

by Imagenetix on September 27, 2005

SAN DIEGO–(BUSINESS WIRE)–Sept. 27, 2005–Imagenetix, Inc. (OTCBB:IAGX – News), www.imagenetix.net a company focused on inflammation and inflammation related markets, today announced the appointment of Jeffrey G. McGonegal to the Imagenetix Board of Directors and his appointment as Chairman of the Audit Committee and the Audit Committee’s Financial Expert. In 1974, Mr. McGonegal began his career [...]

{ Comments on this entry are closed }